亚洲国产精品日韩专区av,涩涩的视频网站,黄色动漫在线免费观看

IBI-363 Shines at ASCO 2025: Innovent’s Breakthrough Immunotherapy Shows Game-Changing Results ASCO Discover how Innovent's IBI-363 made a groundbreaking impact at ASCO 2025 with impressive efficacy in NSCLC, melanoma, and colorectal cancer. A potential game-changer in next-gen immunotherapy.
Chinese Original Weight Loss Drug Featured in NEJM Semaglutide "Mazdutide, a Chinese-developed dual GLP-1/GCG receptor agonist, shows strong weight loss efficacy and safety in a NEJM-published trial, outperforming semaglutide with fewer side effects.
In just half a year, sales soared to 1.5 billion with profits exceeding 600 million—small molecule innovative drugs have successfully established themselves in the domestic market! Chinese Pharmaceutical Market A domestically produced small molecule drug achieved 1.5 billion RMB in sales within six months, proving innovative drugs can thrive in China. Flexible pricing through medical insurance negotiations is reshaping the market, paving the way for future growth and success.

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a